<--- Back to Details
First PageDocument Content
Medicine / Rheumatology / Clinical medicine / Inborn errors of purine-pyrimidine metabolism / Uric acid / Pegloticase / Gout / Urate oxidase / Hyperuricemia / PEGylation / Tophus / ULT
Date: 2016-07-11 16:59:27
Medicine
Rheumatology
Clinical medicine
Inborn errors of purine-pyrimidine metabolism
Uric acid
Pegloticase
Gout
Urate oxidase
Hyperuricemia
PEGylation
Tophus
ULT

Microsoft Word - Savient Press Release ACRdoc

Add to Reading List

Source URL: www.mvpharm.com

Download Document from Source Website

File Size: 35,61 KB

Share Document on Facebook

Similar Documents

Microsoft Word - Savient Press Release ACRdoc

Microsoft Word - Savient Press Release ACRdoc

DocID: 1rrcY - View Document

Microsoft Word - Savient press release re ACRdoc

Microsoft Word - Savient press release re ACRdoc

DocID: 1reUR - View Document

Microsoft Word - Savient press release on ACRdoc

Microsoft Word - Savient press release on ACRdoc

DocID: 1pWM3 - View Document

Puricase(R) (pegloticase) Meets Pre-Specified Primary Efficacy Endpoint in Two Replicate Phase 3 Studies

Puricase(R) (pegloticase) Meets Pre-Specified Primary Efficacy Endpoint in Two Replicate Phase 3 Studies

DocID: 1pRtE - View Document

Microsoft Word - Savient press release re OLEdoc

Microsoft Word - Savient press release re OLEdoc

DocID: 1pDKY - View Document